BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6275141)

  • 1. [Antibacterial activity of mecillinam against E. coli isolated from urinary tract infections (author's transl)].
    Shimizu Y
    Jpn J Antibiot; 1981 Jul; 34(7):1087-91. PubMed ID: 6275141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mecillinam/clavulanate combination: a possible option for the treatment of community-acquired uncomplicated urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
    Lampri N; Galani I; Poulakou G; Katsarolis I; Petrikkos G; Giamarellou H; Souli M
    J Antimicrob Chemother; 2012 Oct; 67(10):2424-8. PubMed ID: 22665388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of subinhibitory concentrations of mecillinam on the serum susceptibility of Escherichia coli strains.
    Taylor PW; Gaunt H; Unger FM
    Antimicrob Agents Chemother; 1981 May; 19(5):786-8. PubMed ID: 6271047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of ampicillin and cefazolin combined with mecillinam (author's transl)].
    Stille W; Bischof-Léger E; Helm EB
    Arzneimittelforschung; 1978; 28(10):1661-4. PubMed ID: 226099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility testing of urinary isolates of Escherichia coli to mecillinam using NCCLS methodology.
    Skov R; Frimodt-Moller N; Menday P; Espersen F
    Int J Antimicrob Agents; 2005 Mar; 25(3):198-204. PubMed ID: 15737512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversion of High-level Mecillinam Resistance to Susceptibility in Escherichia coli During Growth in Urine.
    Thulin E; Thulin M; Andersson DI
    EBioMedicine; 2017 Sep; 23():111-118. PubMed ID: 28855073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combination of mecillinam and amoxicillin/clavulanate can restore susceptibility of high-level TEM-1-producing Escherichia coli to mecillinam.
    Birgy A; Delecourt M; Geslain G; Desselas E; Caseris M; Magnan M; Mariani-Kurkdjian P; Bidet P; Bonacorsi S
    J Antimicrob Chemother; 2017 Jul; 72(7):1911-1914. PubMed ID: 28369441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of antibacterial activity of mecillinam against recently isolated bacilli of 5 genera of Enterobacteriaceae from clinical materials with ampicillin, amoxicillin, cephalexin, nalidixic acid and pipemidic acid (author's transl)].
    Kosakai N; Oguri T
    Jpn J Antibiot; 1979 Aug; 32(8):812-8. PubMed ID: 226736
    [No Abstract]   [Full Text] [Related]  

  • 9. Mecillinam resistance in Escherichia coli: dissociation of growth inhibition and morphologic change.
    Barbour AG; Mayer LW; Spratt BG
    J Infect Dis; 1981 Jan; 143(1):114-21. PubMed ID: 6260864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sensitivity to FL 1060 (mecilliman) of E. coli and Klebsiella pneumoniae isolated from bile (author's transl)].
    Deguchi K
    Jpn J Antibiot; 1980 Mar; 33(3):329-32. PubMed ID: 6249943
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro combination of mecillinam with cephradine or amoxycillin for organisms resistant to single agents.
    Chattopadhyay B; Hall I
    J Antimicrob Chemother; 1979 Sep; 5(5):549-53. PubMed ID: 227829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High and selective resistance to mecillinam in adenylate cyclase-deficient or cyclic adenosine 3',5'-monophosphate receptor protein-deficient mutants of Escherichia coli.
    Aono R; Yamasaki M; Tamura G
    J Bacteriol; 1979 Feb; 137(2):839-45. PubMed ID: 217866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibitory activity of ampicillin and mecillinam on Haemophilus influenzae].
    Dabernat H; Delmas C; Lareng MB
    Pathol Biol (Paris); 1984 May; 32(5):378-80. PubMed ID: 6330648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mecillinam susceptibility of Escherichia coli K-12 mutants deficient in the adenosine 3',5'-monophosphate system.
    Scott NW; Harwood CR
    Antimicrob Agents Chemother; 1981 Apr; 19(4):540-4. PubMed ID: 6264850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of beta-lactamase and the outer-membrane structure in the resistance of Enterobacteriaceae to mecillinam.
    Bongaerts GP; Bruggeman-Ogle K
    Antonie Van Leeuwenhoek; 1980; 46(1):99. PubMed ID: 6249199
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibiotic sensitivity of enteropathogenic Escherichia coli to mecillinam, trimethoprim-sulfamethoxazole and other antibiotics.
    Thorén A
    Acta Pathol Microbiol Scand B; 1980 Oct; 88(5):265-8. PubMed ID: 6258383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virulence of mecillinam-resistant spherical mutants of Klebsiella pneumoniae and Escherichia coli.
    Verweij-van Vught AM; Namavar F; Smit AM; Sparrius M; MacLaren DM
    J Antimicrob Chemother; 1982 May; 9(5):379-85. PubMed ID: 6284694
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the effect of mecillinam upon Micrococcaceae and faecal streptococci under conditions simulating urinary tract infection.
    Anderson JD; Adams MA; Wilson LC; Shepherd CA
    J Antimicrob Chemother; 1976 Dec; 2(4):351-61. PubMed ID: 206530
    [No Abstract]   [Full Text] [Related]  

  • 19. Paradoxical effect of mecillinam on Providencia stuartii.
    Kerry DW; Hamilton-Miller JM; Brumfitt W
    J Antimicrob Chemother; 1976 Dec; 2(4):386-8. PubMed ID: 206531
    [No Abstract]   [Full Text] [Related]  

  • 20. Induction of cell lysis in Escherichia coli: cooperative effect of nocardicin A and mecillinam.
    Berenguer J; de Pedro MA; Vázquez D
    Antimicrob Agents Chemother; 1982 Feb; 21(2):195-200. PubMed ID: 6280596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.